FGFR4 anticorps (AA 25-182)

N° du produit ABIN7152841

Détail du produit anti-FGFR4 anticorps

Antigène: FGFR4 (Fibroblast Growth Factor Receptor 4 (FGFR4))

Épitope: AA 25-182

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp FGFR4 est non-conjugé

Application: ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Fibroblast growth factor receptor 4 protein (25-182AA)

Isotype: IgG

Information d'application

Indications d'application: Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur FGFR4

Antigène: FGFR4 (Fibroblast Growth Factor Receptor 4 (FGFR4))

Autre désignation: FGFR4 (FGFR4 Produits)

Synonymes: anticorps FGFR4, anticorps XFGFR-4, anticorps XFGFR-4a, anticorps cd334, anticorps fgfr-4, anticorps jtk2, anticorps tkf, anticorps xfgfr4, anticorps CD334, anticorps JTK2, anticorps TKF, anticorps Fgfr-4, anticorps etID309818.21, anticorps wu:fc13h10, anticorps zgc:111935, anticorps fgfr-4c, anticorps fgfr4, anticorps fibroblast growth factor receptor 4, anticorps fibroblast growth factor receptor 4 S homeolog, anticorps FGFR4, anticorps fgfr4, anticorps Fgfr4, anticorps fgfr4.S

Sujet:

Background: Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays a role in the regulation of cell proliferation, differentiation and migration, and in regulation of lipid metabolism, bile acid biosynthesis, glucose uptake, vitamin D metabolism and phosphate homeostasis. Required for normal down-regulation of the expression of CYP7A1, the rate-limiting enzyme in bile acid synthesis, in response to FGF19. Phosphorylates PLCG1 and FRS2. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes SRC-dependent phosphorylation of the matrix protease MMP14 and its lysosomal degradation. FGFR4 signaling is down-regulated by receptor internalization and degradation, MMP14 promotes internalization and degradation of FGFR4. Mutations that lead to constitutive kinase activation or impair normal FGFR4 inactivation lead to aberrant signaling.

Aliases: CD 334 antibody, CD334 antibody, CD334 antigen antibody, fc13h 10 antibody, fc13h10 antibody, Fgfr 4 antibody, FGFR-4 antibody, Fgfr4 antibody, FGFR4_HUMAN antibody, Fibroblast growth factor receptor 4 antibody, Hydroxyaryl protein kinase antibody, JTK 2 antibody, JTK2 antibody, MGC20292 antibody, Protein tyrosine kinase antibody, TKF antibody, Tyrosine kinase related to fibroblast growth factor receptor antibody, Tyrosylprotein kinase antibody

UniProt: P22455

Pathways: Signalisation RTK, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Carbohydrate Homeostasis, Growth Factor Binding